📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: GeneLink

1.1 - Company Overview

GeneLink Logo

GeneLink

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of genetic profile development, product development, business development, and support services.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to GeneLink

Unity Biotechnology Logo

Unity Biotechnology

HQ: United States Website
  • Description: Provider of therapeutics to prevent, halt, and reverse diseases of aging, with candidates for age-related eye diseases and neurodegeneration: UBX1325, a Bcl-xL inhibitor in clinical development that selectively eliminates senescent cells in diseased vasculature for conditions including diabetic macular edema; UBX2050, an investigational Tie2-activating monoclonal antibody; and UBX2089, a recombinant α-Klotho protein.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Unity Biotechnology company profile →
IntegraGen Logo

IntegraGen

HQ: France Website
  • Description: Provider of molecular marker development for central nervous system and metabolic diseases, and sequencing/bioinformatics services: exome, custom gene panel, and whole genome sequencing; cancer and genetic disease pipelines; proprietary software for variant selection and clinical-grade results; MERCURY oncology reporting tool; and OncoXPLORE cancer gene panel for biomarker validation and tumor characterization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full IntegraGen company profile →
Denali Therapeutics Logo

Denali Therapeutics

HQ: United States Website
  • Description: Provider of investigational therapeutics focused on neurodegenerative diseases, including BIIB122/DNL151 (LRRK2 inhibitor) for Parkinson’s disease, DNL343 for ALS, SAR443820/DNL788 (RIPK1-targeting) for multiple sclerosis, and TAK-594/DNL593 (PTV:PGRN) for frontotemporal dementia–granulin, as well as DNL310 (ETV:IDS) for Hunter syndrome and DNL126 (ETV:SGSH) for MPS IIIA.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Denali Therapeutics company profile →
Ascenda Bio Logo

Ascenda Bio

HQ: United States Website
  • Description: Provider of molecular PCR and DNA technology with high sensitivity and specificity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ascenda Bio company profile →
Microbiotica Logo

Microbiotica

HQ: United Kingdom Website
  • Description: Provider of human microbiome therapeutics and biomarkers, offering live bacterial therapeutics that engraft in the intestine; microbiome-based biomarkers for drug response, side-effects, or disease progression to stratify patients; a gut bacteria Culture Collection and proprietary Reference Genome Database; advanced microbiome bioinformatics and machine learning; and Personalised Bacterial Banks.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Microbiotica company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for GeneLink

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to GeneLink

2.2 - Growth funds investing in similar companies to GeneLink

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for GeneLink

4.2 - Public trading comparable groups for GeneLink

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to GeneLink

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About GeneLink

What does GeneLink do?

GeneLink is a provider of genetic profile development, product development, business development, and support services.

Who are GeneLink's competitors?

GeneLink's competitors and similar companies include Unity Biotechnology, IntegraGen, Denali Therapeutics, Ascenda Bio, and Microbiotica.

Where is GeneLink headquartered?

GeneLink is headquartered in United States.

How many employees does GeneLink have?

GeneLink has 1,000 employees 🔒.

When was GeneLink founded?

GeneLink was founded in 2010 🔒.

What sector and industry vertical is GeneLink in?

GeneLink is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for GeneLink

Who are the top strategic acquirers in GeneLink's sector and industry

Top strategic M&A buyers and acquirers in GeneLink's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for GeneLink?

Top strategic M&A buyers groups and sectors for GeneLink include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in GeneLink's sector and industry vertical

Which are the top PE firms investing in GeneLink's sector and industry vertical?

Top PE firms investing in GeneLink's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in GeneLink's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in GeneLink's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in GeneLink's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to GeneLink include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in GeneLink's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for GeneLink?

The key public trading comparables and valuation benchmarks for GeneLink include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for GeneLink for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for GeneLink with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in GeneLink's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for GeneLink with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in GeneLink's' sector and industry vertical?

Access recent funding rounds and capital raises in GeneLink's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for GeneLink